Rapid generation of stable cell lines expressing corticotropin-releasing hormone receptor for drug discovery

Protein Expression and Purification

Volumn 9, Issue 3, 1997, Pages 301-308

  Horlick, Robert A ^a,c   Sperle, Karen ^a   Breth, Leah A ^a   Reid, Christian C ^a   Shen, Emily S ^b   Robbins, Alan K ^a   Cooke, Gary M ^a   Largent, Brian L ^a  

^a DUPONT COMPANY   (United States)

^b WYETH AYERST RESEARCH   (United States)

^c PHARMACOPEIA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031127343     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1996.0701     Document Type: Article

References (25)

1. Reisman D., Yates J., Sugden B. A putative origin of replication of plasmids derived from Epstein-Barr Virus is composed of two cis-acting components. Mol. Cell. Biol. 5:1985;1822-1832.
2. Yates J. L., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr Virus in various mammalian cells. Nature. 313:1985;812-815.
3. Swirski R. A., van den Berg D., Murphy A. J. M., Lambert C. M., Friedberg E. C., Schimke R. T. Improvements in the Epstein-Barr-based shuttle vector system for direct cloning in human tissue culture cells. Methods. 4:1992;133-142.
4. Cockett M. I., Bebbington C. R., Yarranton G. T. The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines. Nucleic Acids Res. 19:1991;319-325.
5. Olive D. M., Al-Mulla W., Simsek M., Zarban S., Al-Nakib W. The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S E1A gene. Arch. Virol. 112:1990;67-80.
6. Chen R., Lewis K. A., Perrin M. H., Vale W. W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. USA. 90:1993;8967-8971.
7. Perrin M. H., Donaldson C. J., Chen R., Lewis K. A., Vale W. W. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology. 133:1993;3058-3061.
8. Vita N., Laurent P., Lefort S., Chalon P., Lelias J. M., Kaghad M., Le Fur G., Caput D., Ferrara P. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett. 335:1993;1-5.
9. Xiong Y., Xie L. Y., Abou-Samra A.-B. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: Decreased coupling efficiency of human type II CRF receptor. Endocrinology. 136:1995;1828-1834.
10. Usdin T. B., Mezey E., Button D. C., Brownstein M. J., Bonner T. I. Gastric inhibitory polypeptide receptor, a member of the secretin-VIP receptor family, is widely distributed in peripheral organs and brain. Endocrinology. 133:1993;2861-2871.
11. De Souza E. B., Grigoriadis D. E. Physiology, pharmacology, and role in central nervous system and immune disorders. Psychopharmacology: The Fourth Generation of Progress. 1995;Raven Press, New York. p. 505-517.
12. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor.
13. Hogan B., Costantini F., Lacy E. Manipulating the Mouse Embryo. 1986;Cold Spring Harbor Laboratory, Cold Spring Harbor. p. 174-175.
14. Liaw C. W., Lovenberg T. W., Barry G., Oltersdorf T., Grigoriadis D. E., De Souza E. B. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology. 137:1996;72-77.
15. Shen E. S., Cooke G. M., Horlick R. A. Improved expression cloning using reporter genes and EBV ori-containing vectors. Gene. 156:1995;235-239.
16. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:1977;59-74.
17. James M. R., Stary A., Daya-Grosjean L., Drougard C., Sarasin A. Comparative study of Epstein-Barr virus and SV40-based shuttle-expression vectors in human repair-deficient cells. Mutat. Res. 202:1989;169-185.
18. Adham N., Ellerbrock B., Hartig P. R., Weinshank R. L., Branchek T. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine 1B receptor. Mol. Pharmacol. 43:1993;427-433.
19. Piechaczyk M., Blanchard J. M., Marty L., Dani Ch., Panabieres F., El Sabouty S., Fort Ph., Jeanteur Ph. Post-transcriptional regulation of glyceraldhyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res. 18:1984;6951-6963.
20. Munson P. J., Rodbard D. Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
21. Gorman C. M., Gies D., McCray G., Huang M. The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins. Virology. 171:1989;377-385.
22. Jalanko A., Kallio A., Ruohonen-Lehto M., Söderlund H., Ulmanen I. An EBV-based mammalian cell expression vector for efficient expression of cloned coding sequences. Biochim. Biophys. Acta. 949:1988;205-212.
23. Kozak M. The scanning model for translation - An update. J. Cell. Biol. 108:1989;229-241.
24. Needham M., Egerton M., Millest A., Evans S., Popplewell M., Cerillo G., McPheat J., Monk A., Jack A., Johnstone D., Hollis M. Further development of the locus control region/murine erythroleukemia expression system: High level expression and characterization of recombinant human calcitonin receptor. Protein Expression Purif. 6:1995;124-131.
25. Hay R., Caputo J., Chen T. R., Macy M., McClintock P., Reid Y. ATCC: Catalogue of Cell Lines & Hybridomas. 1992;American Type Culture Collection, Rockville. p. 148-.